- Home
- LNSR vs NRXP Comparison
LNSR vs NRXP Comparison
Compare LNSR & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNSR
- NRXP
- Stock Information
- Founded
- LNSR 2004
- NRXP 2015
- Country
- LNSR United States
- NRXP United States
- Employees
- LNSR N/A
- NRXP N/A
- Industry
- LNSR Medical Electronics
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- LNSR Health Care
- NRXP Health Care
- Exchange
- LNSR Nasdaq
- NRXP Nasdaq
- Market Cap
- LNSR 63.4M
- NRXP 51.3M
- IPO Year
- LNSR N/A
- NRXP N/A
- Fundamental
- Price
- LNSR $9.29
- NRXP $2.28
- Analyst Decision
- LNSR
- NRXP Strong Buy
- Analyst Count
- LNSR 0
- NRXP 3
- Target Price
- LNSR N/A
- NRXP $31.67
- AVG Volume (30 Days)
- LNSR 107.2K
- NRXP 464.9K
- Earning Date
- LNSR 02-27-2025
- NRXP 03-27-2025
- Dividend Yield
- LNSR N/A
- NRXP N/A
- EPS Growth
- LNSR N/A
- NRXP N/A
- EPS
- LNSR N/A
- NRXP N/A
- Revenue
- LNSR $48,868,000.00
- NRXP N/A
- Revenue This Year
- LNSR $25.07
- NRXP N/A
- Revenue Next Year
- LNSR $24.95
- NRXP N/A
- P/E Ratio
- LNSR N/A
- NRXP N/A
- Revenue Growth
- LNSR 21.29
- NRXP N/A
- 52 Week Low
- LNSR $2.67
- NRXP $1.10
- 52 Week High
- LNSR $12.13
- NRXP $7.33
- Technical
- Relative Strength Index (RSI)
- LNSR 42.92
- NRXP 38.85
- Support Level
- LNSR $9.66
- NRXP $2.80
- Resistance Level
- LNSR $11.80
- NRXP $3.07
- Average True Range (ATR)
- LNSR 0.95
- NRXP 0.29
- MACD
- LNSR -0.25
- NRXP -0.10
- Stochastic Oscillator
- LNSR 4.38
- NRXP 2.52
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.